531.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$529.42
Aprire:
$528.32
Volume 24 ore:
1.37M
Relative Volume:
0.64
Capitalizzazione di mercato:
$184.23B
Reddito:
$8.71B
Utile/perdita netta:
$2.48B
Rapporto P/E:
77.98
EPS:
6.82
Flusso di cassa netto:
$1.75B
1 W Prestazione:
+3.46%
1M Prestazione:
+17.77%
6M Prestazione:
+3.23%
1 anno Prestazione:
+39.45%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Confronta ISRG con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ISRG
Intuitive Surgical Inc
|
531.82 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
167.00 | 58.65B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
97.38 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
240.66 | 35.34B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
81.57 | 16.25B | 3.90B | 392.30M | 288.10M | 1.95 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
2024-07-10 | Reiterato | Citigroup | Buy |
2024-05-30 | Iniziato | Goldman | Buy |
2023-11-17 | Iniziato | HSBC Securities | Buy |
2023-07-19 | Iniziato | Robert W. Baird | Outperform |
2023-04-19 | Reiterato | BTIG Research | Buy |
2023-04-19 | Reiterato | BofA Securities | Buy |
2023-04-19 | Reiterato | Citigroup | Buy |
2023-04-19 | Reiterato | Evercore ISI | In-line |
2023-04-19 | Reiterato | JP Morgan | Overweight |
2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
2023-04-19 | Reiterato | Raymond James | Outperform |
2023-04-19 | Reiterato | Stifel | Buy |
2023-04-19 | Reiterato | Truist | Buy |
2023-04-19 | Reiterato | Wells Fargo | Overweight |
2023-03-29 | Iniziato | UBS | Neutral |
2023-03-23 | Iniziato | William Blair | Outperform |
2022-10-18 | Iniziato | Barclays | Overweight |
2022-10-13 | Iniziato | Mizuho | Neutral |
2022-10-12 | Iniziato | Jefferies | Hold |
2022-04-13 | Iniziato | Truist | Buy |
2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
2022-03-02 | Ripresa | BofA Securities | Buy |
2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-01-25 | Downgrade | Redburn | Buy → Neutral |
2022-01-21 | Reiterato | BTIG Research | Buy |
2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
2022-01-21 | Reiterato | Deutsche Bank | Hold |
2022-01-21 | Reiterato | Evercore ISI | In-line |
2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
2022-01-21 | Reiterato | Piper Sandler | Neutral |
2022-01-21 | Reiterato | Raymond James | Outperform |
2022-01-21 | Reiterato | Robert W. Baird | Outperform |
2022-01-21 | Reiterato | Stifel | Buy |
2022-01-21 | Reiterato | UBS | Neutral |
2022-01-21 | Reiterato | Wells Fargo | Overweight |
2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
2021-07-21 | Reiterato | BofA Securities | Neutral |
2021-07-21 | Reiterato | Citigroup | Buy |
2021-07-21 | Reiterato | JP Morgan | Overweight |
2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
2021-07-21 | Reiterato | Piper Sandler | Neutral |
2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
2021-07-21 | Reiterato | Stifel | Buy |
2021-07-21 | Reiterato | UBS | Neutral |
2021-07-21 | Reiterato | Wells Fargo | Overweight |
2021-07-14 | Reiterato | Goldman | Buy |
2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-04-01 | Iniziato | Citigroup | Buy |
2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-09-28 | Iniziato | Argus | Buy |
2020-09-11 | Iniziato | Wolfe Research | Outperform |
2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
2020-09-02 | Iniziato | Robert W. Baird | Neutral |
2020-07-20 | Reiterato | Bernstein | Outperform |
2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-04-17 | Downgrade | CFRA | Hold → Sell |
2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
2019-12-12 | Reiterato | Wells Fargo | Outperform |
2019-11-21 | Iniziato | Oppenheimer | Perform |
2019-07-19 | Reiterato | Canaccord Genuity | Buy |
2019-04-22 | Reiterato | Canaccord Genuity | Buy |
2019-04-02 | Iniziato | Deutsche Bank | Buy |
2018-10-31 | Reiterato | Piper Jaffray | Overweight |
2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
Short-seller Wolfpack Research long Intuitive Surgical - Investing.com
Wolfpack Research Says Long Intuitive Surgical - marketscreener.com
Intuitive Surgical (ISRG) Impacts UFP Technologies' Business Out - GuruFocus
Intuitive Surgical (ISRG) Announces Key Approvals and Stock Repurchase Program Expansion - GuruFocus
Intuitive Surgical (ISRG) Boosts Share Buyback Program to $4 Billion - GuruFocus
Intuitive Surgical Expands Stock Repurchase Program to $4B - TipRanks
Urology Robotics Devices Market to Reach $28.57 Billion by 2033 | CAGR 17.7% | Intuitive Surgical, MicroPort, Asensus - openPR.com
Intuitive Surgical Boosts Stock Repurchase Program To $4 Billion - marketscreener.com
Is Intuitive Surgical (ISRG) The Best Stock to Buy and Hold For 10 Years? - Insider Monkey
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
Prediction: 2 Stocks Will Be Worth More Than Palantir Technologies in 2026 - Yahoo Finance
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, David Einhorn, Point72 Asset Management, Irenic Capital Management, Balyasny Asset Management, Phinia Inc (PHIN), Intuitive Surgical Inc (ISRG), and More - Insider Monkey
Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility - MedTech Dive
Healthcare Skill Training: Intuitive Surgical India Partners with HSSC - Rediff
Medtech companies try to head off price increases after tariffs - Modern Healthcare
Laparoscopic Surgical Robot Market New Product Development & - openPR.com
Intuitive Surgical Insider Sold Shares Worth $1,248,000, According to a Recent SEC Filing - marketscreener.com
Intuitive Surgical director Amy Ladd sells $4.44m in stock By Investing.com - Investing.com South Africa
Intuitive Surgical director Amy Ladd sells $4.44m in stock - Investing.com Australia
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock By Investing.com - Investing.com Nigeria
Intuitive's (ISRG) da Vinci SP System Gains FDA Approval for New Surgical Procedure | ISRG Stock News - GuruFocus
Intuitive surgical director Jami Nachtsheim sells $1.25m in stock - Investing.com
Jim Cramer on Intuitive Surgical, Inc. (ISRG): ‘As Relevant As Ever’ - Insider Monkey
Intuitive Surgical (ISRG) Expands FDA Clearance for da Vinci Sys - GuruFocus
FDA Expands Intuitive Surgical (NasdaqGS:ISRG) da Vinci SP System for Advanced Colorectal Surgeries - Yahoo Finance
Intuitive’s da Vinci SP Wins FDA Nod for Transanal Local Excision/Resection - Medical Product Outsourcing
Intuitive Surgical Receives US FDA Approval for da Vinci Single Port Surgical System - marketscreener.com
Intuitive's da Vinci Single Port system granted new FDA nod (ISRG) - Seeking Alpha
Intuitive earns expanded FDA nod for da Vinci single port system - MassDevice
Intuitive Announces FDA Clearance Of Da Vinci Single Port For Transanal Local Excision/Resection - marketscreener.com
Intuitive Surgical, Inc. (ISRG): Among the Best Stocks to Buy During Recession - Insider Monkey
FDA approves new da Vinci system for colorectal surgery - Investing.com
Intuitive Announces FDA Clearance of da Vinci Single Port for Tr - GuruFocus
Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection - GlobeNewswire
Trump's Tariffs Could Impact This Top Growth Stock. Here's Why It's Still a Buy - The Motley Fool
Argus Cuts Price Target on Intuitive Surgical to $600 From $630 - marketscreener.com
Intuitive and HSSC come together to strengthen India’s healthcare workforce - Pharmabiz.com
Laparoscopic Devices Market Generated Opportunities, Future - openPR.com
Silicon Valley company's robotic technology helping fight cancer - NBC Bay Area
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - MSN
ISRG Vs. SYK: Which Robotic-Device Innovator Is A Better Buy? - Barchart.com
ISRG vs. SYK: Which Robotic-Device Innovator Is a Better Buy? - Zacks Investment Research
Medtronic submits Hugo soft tissue robot for FDA approval - MedTech Dive
How Big a Threat Is China to Intuitive Surgical Stock? - Nanalyze
Surgical robot officially revealed - Winnipeg Free Press
This Buy-Rated Robotics Stock Has An Unmatched Position - Barchart.com
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Look at Its 11.94% Potential Upside for Investors - DirectorsTalk Interviews
Tariffs are hitting surgical robots and pacemakers, but device companies aren’t sweating it, yet - statnews.com
Intuitive Surgical, Inc. (ISRG): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - Insider Monkey
ISRG Stock Quote Price and Forecast - CNN
Is Intuitive Surgical a Buy After Volatile Reaction to Earnings? - MSN
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):